Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms

[1]  S. Bhattacharyya,et al.  Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid , 2017, Front. Immunol..

[2]  R. Frye,et al.  Mitochondrial dysfunction in the gastrointestinal mucosa of children with autism: A blinded case-control study , 2017, PloS one.

[3]  A. Nadeem,et al.  Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism , 2016, Molecular Neurobiology.

[4]  R. Frye,et al.  Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines , 2016, Translational Psychiatry.

[5]  J. Sandberg,et al.  Mental health service utilization in autism spectrum disorders , 2016 .

[6]  Hyunju Kim,et al.  The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring , 2016, Science.

[7]  Y. Ohno,et al.  Sleep problems are more frequent and associated with problematic behaviors in preschoolers with autism spectrum disorder. , 2016, Research in developmental disabilities.

[8]  C. Rosenfeld.  Microbiome Disturbances and Autism Spectrum Disorders , 2015, Drug Metabolism and Disposition.

[9]  D. Frank,et al.  Comparison of Fecal Microbiota in Children with Autism Spectrum Disorders and Neurotypical Siblings in the Simons Simplex Collection , 2015, PloS one.

[10]  Liza Konnikova,et al.  Individual intestinal symbionts induce a distinct population of RORγ+ regulatory T cells , 2015, Science.

[11]  C. Schumann,et al.  Atypical miRNA expression in temporal cortex associated with dysregulation of immune, cell cycle, and other pathways in autism spectrum disorders , 2015, Molecular Autism.

[12]  K. Xia,et al.  Investigation of Gene Regulatory Networks Associated with Autism Spectrum Disorder Based on MiRNA Expression in China , 2015, PloS one.

[13]  D. Macfabe.  Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders , 2015, Microbial ecology in health and disease.

[14]  R. Frye,et al.  Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome , 2015, Microbial ecology in health and disease.

[15]  D. Ostatníková,et al.  Gastrointestinal microbiota in children with autism in Slovakia , 2015, Physiology & Behavior.

[16]  P. Ashwood,et al.  Immunology of Autism , 2015 .

[17]  A. Davidow,et al.  Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: an inflammatory subtype? , 2014, Journal of Neuroinflammation.

[18]  N. Mori,et al.  Serum microRNA profiles in children with autism , 2014, Molecular Autism.

[19]  I. Hertz-Picciotto,et al.  Gastrointestinal Problems in Children with Autism, Developmental Delays or Typical Development , 2013, Journal of Autism and Developmental Disorders.

[20]  H. Nawa,et al.  mTOR signaling and its roles in normal and abnormal brain development , 2014, Front. Mol. Neurosci..

[21]  M. Angley,et al.  Gastrointestinal microbiota and metabolite biomarkers in children with autism spectrum disorders. , 2014, Biomarkers in medicine.

[22]  Z. Warren,et al.  Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014 , 2018, Morbidity and mortality weekly report. Surveillance summaries.

[23]  Stephen J. Guter,et al.  Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders , 2014, American journal of human genetics.

[24]  Jacques Ravel,et al.  An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform , 2014, Microbiome.

[25]  T. Darville,et al.  Role of Neutrophils in IL-17–Dependent Immunity to Mucosal Candidiasis , 2014, The Journal of Immunology.

[26]  L. Desbonnet,et al.  Microbiota is essential for social development in the mouse , 2013, Molecular Psychiatry.

[27]  O. Healy,et al.  An investigation of comorbid psychological disorders, sleep problems, gastrointestinal symptoms and epilepsy in children and adolescents with Autism Spectrum Disorder , 2016 .

[28]  M. Angley,et al.  Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder , 2013, Molecular Autism.

[29]  Jiahuai Han,et al.  Recognition of gut microbiota by NOD2 is essential for the homeostasis of intestinal intraepithelial lymphocytes , 2013, The Journal of Experimental Medicine.

[30]  Jiahuai Han,et al.  Recognition of gut microbiota by NOD2 is essential for the homeostasis of intestinal intraepithelial lymphocytes , 2013, The Journal of experimental medicine.

[31]  Barbara M. Bakker,et al.  The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism , 2013, Journal of Lipid Research.

[32]  Jesse R. Zaneveld,et al.  Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences , 2013, Nature Biotechnology.

[33]  J. Wehkamp,et al.  Antimicrobial peptides and gut microbiota in homeostasis and pathology , 2013, EMBO molecular medicine.

[34]  Joshua LaBaer,et al.  Reduced Incidence of Prevotella and Other Fermenters in Intestinal Microflora of Autistic Children , 2013, PloS one.

[35]  S. Winter,et al.  Streptomycin-Induced Inflammation Enhances Escherichia coli Gut Colonization Through Nitrate Respiration , 2013, mBio.

[36]  F. Powrie,et al.  Regulatory T cells and immune tolerance in the intestine. , 2013, Cold Spring Harbor perspectives in biology.

[37]  Susan Holmes,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[38]  Sanjai J. Parikh,et al.  Host-Derived Nitrate Boosts Growth of E. coli in the Inflamed Gut , 2013, Science.

[39]  R. Frye,et al.  Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder , 2013, Translational Psychiatry.

[40]  D. Coury,et al.  Gastrointestinal Conditions in Children With Autism Spectrum Disorder , 2012 .

[41]  A. Macpherson,et al.  Interactions Between the Microbiota and the Immune System , 2012, Science.

[42]  P. Ashwood,et al.  The role of immune dysfunction in the pathophysiology of autism , 2012, Brain, Behavior, and Immunity.

[43]  O. Vaarala,et al.  Up‐regulation of small intestinal interleukin‐17 immunity in untreated coeliac disease but not in potential coeliac disease or in type 1 diabetes , 2012, Clinical and experimental immunology.

[44]  Eric P. Nawrocki,et al.  An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea , 2011, The ISME Journal.

[45]  C. Lajonchere,et al.  Genetic heritability and shared environmental factors among twin pairs with autism. , 2011, Archives of general psychiatry.

[46]  Steven Salzberg,et al.  BIOINFORMATICS ORIGINAL PAPER , 2004 .

[47]  N. Mantis,et al.  Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut , 2011, Mucosal Immunology.

[48]  R. Curi,et al.  Regulation of Inflammation by Short Chain Fatty Acids , 2011, Nutrients.

[49]  W. Lipkin,et al.  Impaired Carbohydrate Digestion and Transport and Mucosal Dysbiosis in the Intestines of Children with Autism and Gastrointestinal Disturbances , 2011, PloS one.

[50]  D. Streck,et al.  Children with autism spectrum disorders (ASD) who exhibit chronic gastrointestinal (GI) symptoms and marked fluctuation of behavioral symptoms exhibit distinct innate immune abnormalities and transcriptional profiles of peripheral blood (PB) monocytes , 2011, Journal of Neuroimmunology.

[51]  D. Philpott,et al.  Peptidoglycan: a critical activator of the mammalian immune system during infection and homeostasis , 2011, Immunological reviews.

[52]  C. Alzheimer,et al.  More than being protective: functional roles for TGF-β/activin signaling pathways at central synapses , 2011, Trends in Neurosciences.

[53]  Rob Knight,et al.  UCHIME improves sensitivity and speed of chimera detection , 2011, Bioinform..

[54]  Richard A. Flavell,et al.  NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.

[55]  P. Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[56]  V. Napolioni,et al.  Haptoglobin (HP) polymorphisms and human longevity: a cross-sectional association study in a Central Italy population. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[57]  T. Waldmann,et al.  Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens , 2011, Nature.

[58]  M. Bauman,et al.  Medical comorbidities in autism: Challenges to diagnosis and treatment , 2010, Neurotherapeutics.

[59]  S. Mazmanian,et al.  Has the Microbiota Played a Critical Role in the Evolution of the Adaptive Immune System? , 2010, Science.

[60]  Carmela Bravaccio,et al.  Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First-degree Relatives , 2010, Journal of pediatric gastroenterology and nutrition.

[61]  Robert C. Edgar,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2001 .

[62]  Eunseog Youn,et al.  Pyrosequencing study of fecal microflora of autistic and control children. , 2010, Anaerobe.

[63]  R. Flavell,et al.  The dual nature of TH17 cells: shifting the focus to function , 2010, Nature Immunology.

[64]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[65]  R. Ley,et al.  Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5 , 2010, Science.

[66]  Philip J Landrigan,et al.  What causes autism? Exploring the environmental contribution , 2010, Current opinion in pediatrics.

[67]  F. Barale,et al.  Low-grade endotoxemia in patients with severe autism , 2010, Neuroscience Letters.

[68]  P. Ashwood,et al.  Differential monocyte responses to TLR ligands in children with autism spectrum disorders , 2010, Brain, Behavior, and Immunity.

[69]  S. Genuis,et al.  Celiac Disease Presenting as Autism , 2010, Journal of child neurology.

[70]  Pat Levitt,et al.  Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report , 2010, Pediatrics.

[71]  A. Fasano,et al.  Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2 , 2009, Proceedings of the National Academy of Sciences.

[72]  J. Bluestone,et al.  Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo , 2009, Nature Immunology.

[73]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[74]  T. Furuichi,et al.  Developmentally Regulated Ca2+-Dependent Activator Protein for Secretion 2 (CAPS2) is Involved in BDNF Secretion and is Associated with Autism Susceptibility , 2009, The Cerebellum.

[75]  B. Malissen,et al.  Heterogeneity of natural Foxp3+ T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity , 2009, Proceedings of the National Academy of Sciences.

[76]  Paula Krakowiak,et al.  Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes , 2008, Journal of Neuroimmunology.

[77]  P. Ascenzi,et al.  Human haptoglobin structure and function – a molecular modelling study , 2008, The FEBS journal.

[78]  D. Geschwind.  Autism: Many Genes, Common Pathways? , 2008, Cell.

[79]  A. Levy,et al.  Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular disease. , 2008, Pharmacogenomics (London).

[80]  D. Riethmacher,et al.  In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells , 2008, The Journal of experimental medicine.

[81]  F. Powrie,et al.  Dendritic cells in intestinal immune regulation , 2008, Nature Reviews Immunology.

[82]  D. Geschwind,et al.  Advances in autism genetics: on the threshold of a new neurobiology , 2008, Nature Reviews Genetics.

[83]  G. Veres,et al.  Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestations. , 2008, Clinical chemistry.

[84]  M. Brimacombe,et al.  Autism Spectrum Disorders: Concurrent Clinical Disorders , 2008, Journal of child neurology.

[85]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[86]  K. Hashimoto,et al.  Decreased serum levels of transforming growth factor-β1 in patients with autism , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[87]  M. G. Ferrari,et al.  Utilizing IL-12, IL-15 and IL-7 as Mucosal Vaccine Adjuvants. , 2006, Letters in drug design & discovery.

[88]  Y. Iwakura,et al.  The IL-23/IL-17 axis in inflammation. , 2006, The Journal of clinical investigation.

[89]  Irva Hertz-Picciotto,et al.  The CHARGE Study: An Epidemiologic Investigation of Genetic and Environmental Factors Contributing to Autism , 2006, Environmental health perspectives.

[90]  C. Lord,et al.  Early Medical History of Children with Autism Spectrum Disorders , 2006, Journal of developmental and behavioral pediatrics : JDBP.

[91]  I. Rapin,et al.  Frequency of Gastrointestinal Symptoms in Children with Autistic Spectrum Disorders and Association with Family History of Autoimmune Disease , 2006, Journal of developmental and behavioral pediatrics : JDBP.

[92]  Anne L McCartney,et al.  Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. , 2005, Journal of medical microbiology.

[93]  A. Fasano,et al.  Coeliac disease in children. , 2005, Best practice & research. Clinical gastroenterology.

[94]  M. Karin,et al.  NOD2 and Crohn's disease: loss or gain of function? , 2005, Immunity.

[95]  G. Núñez,et al.  Peptidoglycan Signaling in Innate Immunity and Inflammatory Disease* , 2005, Journal of Biological Chemistry.

[96]  K. Bushara.  Neurologic presentation of celiac disease. , 2005, Gastroenterology.

[97]  P. Ashwood,et al.  Spontaneous Mucosal Lymphocyte Cytokine Profiles in Children with Autism and Gastrointestinal Symptoms: Mucosal Immune Activation and Reduced Counter Regulatory Interleukin-10 , 2004, Journal of Clinical Immunology.

[98]  S. Finegold,et al.  Real-Time PCR Quantitation of Clostridia in Feces of Autistic Children , 2004, Applied and Environmental Microbiology.

[99]  B. Franke,et al.  NOD2 mediates anti‐inflammatory signals induced by TLR2 ligands: implications for Crohn's disease , 2004, European journal of immunology.

[100]  M. Thomson,et al.  Focal-Enhanced Gastritis in Regressive Autism with Features Distinct from Crohn's and Helicobacter Pylori Gastritis , 2004, American Journal of Gastroenterology.

[101]  P. Ashwood,et al.  Intestinal Lymphocyte Populations in Children with Regressive Autism: Evidence for Extensive Mucosal Immunopathology , 2003, Journal of Clinical Immunology.

[102]  Vahid Asnafi,et al.  Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. , 2003, Gastroenterology.

[103]  P. Manning-Courtney,et al.  Prevalence of Chronic Gastrointestinal Symptoms in Children with Autism and Autistic Spectrum Disorders , 2003, Autism : the international journal of research and practice.

[104]  H. Jyonouchi,et al.  Innate Immunity Associated with Inflammatory Responses and Cytokine Production against Common Dietary Proteins in Patients with Autism Spectrum Disorder , 2002, Neuropsychobiology.

[105]  Haroun Shah,et al.  Gastrointestinal microflora studies in late-onset autism. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[106]  D. Drossman,et al.  Irritable bowel syndrome: classification and conceptualization. , 2002, Journal of clinical gastroenterology.

[107]  Karoly Horvath,et al.  Autism and gastrointestinal symptoms , 2002, Current gastroenterology reports.

[108]  G. Davies-Jones,et al.  Gluten sensitivity as a neurological illness , 2002, Journal of neurology, neurosurgery, and psychiatry.

[109]  R Day,et al.  Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism , 2002, Molecular Psychiatry.

[110]  A. Levy,et al.  Structure-function analysis of the antioxidant properties of haptoglobin. , 2001, Blood.

[111]  R Day,et al.  Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. , 2001, The Journal of pediatrics.

[112]  D. Drossman,et al.  Psychosocial aspects of Crohn's disease. , 2001, The Surgical clinics of North America.

[113]  Harumi Jyonouchi,et al.  Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression , 2001, Journal of Neuroimmunology.

[114]  S. Maier,et al.  Vagal immune-to-brain communication: a visceral chemosensory pathway , 2000, Autonomic Neuroscience.

[115]  C. Gillberg and,et al.  Autism and Asperger syndrome: coexistence with other clinical disorders , 2000, Acta psychiatrica Scandinavica.

[116]  D. De Bacquer,et al.  Haptoglobin polymorphism and mortality in patients with tuberculosis. , 2004 .

[117]  C. Achim,et al.  Haptoglobin polymorphism, iron metabolism and mortality in HIV infection , 1998 .

[118]  P. D'eufemia,et al.  Abnormal intestinal permeability in children with autism , 1996, Acta paediatrica.

[119]  R. Cortese,et al.  The human haptoglobin gene promoter: interleukin‐6‐responsive elements interact with a DNA‐binding protein induced by interleukin‐6. , 1989, The EMBO journal.

[120]  V. Paetkau,et al.  The role of IL-5 in IgA B cell differentiation. , 1988, Journal of immunology.

[121]  G. Sedvall,et al.  Psychic Disturbances in Adult Coeliac Disease , 1982 .

[122]  C. Hallert,et al.  Psychic disturbances in adult coeliac disease. I. Clinical observations. , 1982, Scandinavian journal of gastroenterology.

[123]  J. Walker-Smith,et al.  ALPHA-1-ANTITRYPSIN, AUTISM, AND CŒLIAC DISEASE , 1972 .

[124]  L. Kanner.  Autistic disturbances of affective contact. , 1968, Acta paedopsychiatrica.

[125]  H. Asperger.  [Psychopathology of children with coeliac disease]. , 1961, Annales paediatrici. International review of pediatrics.